Literature DB >> 9514432

Transanal approach to rectocele repair may compromise anal sphincter pressures.

Y H Ho1, M Ang, D Nyam, M Tan, F Seow-Choen.   

Abstract

PURPOSE: This study prospectively assessed the functional results, particularly anal sphincter impairment, following transanal repair of rectocele for chronic intractable constipation.
METHOD: Twenty-one consecutive women (mean age, 47.7 (standard error of the mean, 2.7) years) had the diagnosis of rectocele obstructing defecation made on synchronized anal manometry, electromyography, and cinedefecography. All underwent a standardized transanal repair with controlled anal stretching (maximum of 4 cm) from self-retaining anal retractors. The clinical function and anorectal manometry were assessed before surgery and were repeated six months later.
RESULTS: All 21 patients were subjectively satisfied with the relief from constipation after surgery. There were significant improvements in the straining at defecation (before, n = 19; after, n = 3; P = 0.001), need to digitate per vagina (before, n = 16; after, n = 0; P = 0.001), stool frequency (before, 3.8 (0.7) times weekly; after, 8.6 (1.2); P = 0.004), and laxative requirements (before, n = 7; after, n = 0; P = 0.03). Although none were clinically incontinent, there was a mean 28 mmHg impairment in resting (P < 0.05) and 42.6 mmHg impairment in maximum squeeze anal pressures (P < 0.05) after operations. There was no other morbidity.
CONCLUSION: Transanal rectocele repair effectively improves constipation problems, at the risk of impaired anal sphincter function. Although clinical incontinence was minimum, an alternative approach to rectocele repair should be considered when anal sphincters are lax.

Entities:  

Mesh:

Year:  1998        PMID: 9514432     DOI: 10.1007/bf02237491

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

Review 1.  Rectocele: pathogenesis and surgical management.

Authors:  A P Zbar; A Lienemann; H Fritsch; M Beer-Gabel; M Pescatori
Journal:  Int J Colorectal Dis       Date:  2003-03-29       Impact factor: 2.571

2.  Long-term results of stapled transanal rectal resection (STARR) for obstructive defecation syndrome.

Authors:  Andreas Ommer; Thomas M Rolfs; Martin K Walz
Journal:  Int J Colorectal Dis       Date:  2010-08-19       Impact factor: 2.571

3.  A 2-year anatomical and functional assessment of transvaginal rectocele repair using a polypropylene mesh.

Authors:  Renaud de Tayrac; Olivier Picone; Aurélia Chauveaud-Lambling; Hervé Fernandez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-05-21

4.  Stapled transanal rectal resection (STARR): a new option in the treatment of obstructive defecation syndrome.

Authors:  A Ommer; K Albrecht; F Wenger; M K Walz
Journal:  Langenbecks Arch Surg       Date:  2006-01-10       Impact factor: 3.445

5.  Functional disorders: rectocele.

Authors:  Roger Lefevre; G Willy Davila
Journal:  Clin Colon Rectal Surg       Date:  2008-05

6.  Treatment of obstructed defecation.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-05

7.  Treatment of obstructed defecation.

Authors:  C Neal Ellis; Rahila Essani
Journal:  Clin Colon Rectal Surg       Date:  2012-03

8.  Rectocele repair improves evacuation and prolapse complaints independent of anorectal function and colonic transit time.

Authors:  C E J Sloots; A J Meulen; R J F Felt-Bersma
Journal:  Int J Colorectal Dis       Date:  2003-02-04       Impact factor: 2.571

9.  Randomized controlled trial between perineal and anal repairs of rectocele in obstructed defecation.

Authors:  Mohamed Farid; Khaled M Madbouly; Ahmed Hussein; Tarik Mahdy; Hesham A Moneim; Waleed Omar
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

10.  Proctalgia in a patient with staples retained in the puborectalis muscle after STARR operation.

Authors:  P De Nardi; C Bottini; L Faticanti Scucchi; A Palazzi; M Pescatori
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.